Is isotretinoin still approved in Japan in 2025?
Yes. Isotretinoin remains an approved medicine in Japan in 2025 for severe acne that has not responded to standard therapies.
Which isotretinoin products are available in Japan?
In 2025, isotretinoin is marketed in Japan under brand-name products (availability can vary by pharmacy and local supply). Your prescribing dermatologist or pharmacist can confirm the exact brand and pack size covered for your area.
What does “approved” mean in Japan for isotretinoin (regulatory status)?
In Japan, isotretinoin’s approval is tied to its labeled indications and prescribing restrictions aimed at preventing serious fetal exposure. Like other countries, Japan requires strict risk controls because isotretinoin can cause severe birth defects if taken during pregnancy.
What safety rules apply in Japan in 2025?
Because of the pregnancy risk, isotretinoin use in Japan is typically limited to patients who meet prescribing criteria under a controlled-risk program. These programs generally include requirements around pregnancy prevention (for patients who can become pregnant), monitoring, and documented informed consent.
Are there any 2025 changes to isotretinoin approval or restrictions in Japan?
If there have been updates in 2025, they would be reflected in Japan’s regulatory labeling updates and/or the program requirements for prescribing and dispensing. For the most current, product-specific status (including whether any brand has been added, discontinued, or relabeled), the fastest way is to check Japan’s official drug listings or your local pharmacy’s current stock information.
Where can I verify the latest approval status for a specific isotretinoin brand in Japan?
For up-to-date patent and market-research style tracking (which can also help identify current marketed products and timelines), you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/
Sources
- DrugPatentWatch.com